Literature DB >> 18975584

[Intestinal colonization and nosocomial spread of Clostridium difficile in pediatric cancer patients under long-term hospitalization].

Mayumi Murabata1, Haru Kato, Hisako Yano, Masamichi Ogura, Junko Shibayama, Yukio Wakimoto, Yoshichika Arakawa, Masashi Mizokami.   

Abstract

Clostridium difficile is a major causative agent of antimicrobial-associated diarrhea, and the leading cause of nosocomial diarrhea. We clarified intestinal colonization and nosocomial spread of C. difficile in pediatric cancer patients undergoing antineoplastic therapy during long-term hospitalization. Subjects were 10 children with pediatric malignant diseases admitted from November 2005 to December 2006, aged 5 to 15 years, who received antineoplastic agents. Stool specimens were examined at hospitalization, after each course of treatment with antineoplastic chemotherapy, and when symptoms such as diarrhea or fever occurred. While C. difficile was detected from stool specimens of 8 of 10 children during their hospital stay, 6 of these 8 children were negative for C. difficile on the day of their admission. These results demonstrate that the use of antimicrobial agents and antineoplastic agents lead to overgrowth of C. difficile in intestinal tract of pediatric cancer patients. Five of the 8 children carried toxin A-positive, toxin B-positive C. difficle and 2 were diagnosed with C. difficile-associated diarrhea (CDAD). This demonstrates that CDAD is not a rare infection in pediatric cancer patients. Nine C. difficile isolates from 8 children were analyzed by PCR ribotyping. Two isolates from 2 children were typed into the same type;banding patterns of the remaining 7 isolates from 6 children were unique.

Entities:  

Mesh:

Year:  2008        PMID: 18975584     DOI: 10.11150/kansenshogakuzasshi1970.82.419

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  5 in total

1.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

2.  Pancreatic disease patients are at higher risk for Clostridium difficile infection compared to those with other co-morbidities.

Authors:  Chetana Vaishnavi; Pramod K Gupta; Megha Sharma; Rakesh Kochhar
Journal:  Gut Pathog       Date:  2019-04-23       Impact factor: 4.181

3.  The Role of Glutamate Dehydrogenase (GDH) Testing Assay in the Diagnosis of Clostridium difficile Infections: A High Sensitive Screening Test and an Essential Step in the Proposed Laboratory Diagnosis Workflow for Developing Countries like China.

Authors:  Jing-Wei Cheng; Meng Xiao; Timothy Kudinha; Zhi-Peng Xu; Lin-Ying Sun; Xin Hou; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

4.  Colonization with Clostridium difficile in Children with Cancer.

Authors:  Shahnaz Armin; Shahin Shamsian; Hojatollah Drakhshanfar
Journal:  Iran J Pediatr       Date:  2013-08       Impact factor: 0.364

5.  The First Two Clostridium difficile Ribotype 027/ST1 Isolates Identified in Beijing, China-an Emerging Problem or a Neglected Threat?

Authors:  Jing-Wei Cheng; Meng Xiao; Timothy Kudinha; Zhi-Peng Xu; Xin Hou; Lin-Ying Sun; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.